H.C. Wainwright Global Life Sciences Conference
Events
Chardan’s virtual 3rd Annual Microbiome Medicines Summit
Events
Crohn’s & Colitis Congress
Events
Biomica Announces Participation at the Crohn’s & Colitis Congress® January 21-24, 2021 (Virtual Conference)
Press Releases
Rehovot, Israel – January 21, 2020 – Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN.TA), today announced it will be featured as a presenting company at the Crohn’s & Colitis Congress® to be held from today January 21-24,
5th Microbiome Movement Drug Development Europe Conference
Events
Biomica Announces Participation at the 5th Microbiome Movement Drug Development Europe Conference on January 28-29, 2021 (Virtual Conference)
Press Releases
Rehovot, Israel – January 20, 2021 – Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN.TA), today announced it will be featured as a presenting company at the Microbiome Movement Drug Development Europe Conference.
H.C. Wainwright 6th Annual Israel Conference
Events
Pharmabiotics Online Web Series
Events
Biomica Announces Initiation of Large-Scale Production of Live Bacterial Product (LBP) Candidate Consortium in its Immuno-Oncology Program
Press Releases
The company is advancing to scale-up and GMP batch production, to support anticipated first-in-man proof-of-concept clinical trials next year
Rehovot, Israel – October 13, 2020 – Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN),
Biomica Announces Participation at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)
Press Releases
Rehovot, Israel – September 9, 2020 – Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN.TA), today announced it will be featured as a presenting company at the H.C. Wainwright 22nd Annual Global Investment Conference.